Showing results (311-320 of 392) with videos related to

Sort By:
Pageof 40
Clinical and Experimental Obstetrics & Gynecology|May 16, 2002
A survey of physicians' attitude and approach to hormone replacement therapy during menopuaseB Kaplan, D Rabinerson, Y Yogev, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Pregnancy and multiple sclerosis: a 2-year experienceR Orvieto, R Achiron, Z Rotstein, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1989
Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilizationS Mashiach, J Dor, M Goldenberg, et al.
Clinical and Experimental Obstetrics & Gynecology|July 23, 2004
Serum and follicular fluid leptin levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycleR Chen, B Fisch, A Ben-Haroush, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 23, 1999
In vitro modulation of activation antigens on human lymphocytes by beta-estradiolL Komlos, Z Zahavi, D Dicker, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 1, 1984
Ovarian melanoma. An interesting caseM Ben David, D Feldberg, D Dicker, et al.
Clinical and Experimental Obstetrics & Gynecology|April 30, 2009
The possible influence of increased body mass index on the clinical efficacy of standard human chorionic gonadotropin dosageJ Ashkenazi, I Bar-Hava, S Meltcer, et al.
Clinical and Experimental Obstetrics & Gynecology|February 12, 2009
Early endometrial changes following successful implantation: 2 and 3-dimensional ultrasound studyE Zohav, I Bar-Hava, S Meltcer, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 25, 2005
Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilizationO M Avrech, R Orvieto, H Pinkas, et al.
Human Reproduction (Oxford, England)|December 6, 2021
Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort studyR Machtinger, N Fallach, I Goldstein, et al.
Pageof 40